Pharmaceutical components of c-hemophilia derivatives and class I interference mixtures for the treatment of hypoxic brain diseases and neurodegenerative diseases
The invention describes the pharmaceutical components composed of c-ficocaine derivatives, such as the chromosomal peptide (fcb-aa) of the Red Cross and Red Crescent society or the Red Cross and Red Crescent society,As well as the medical use of compounds that have been proved to have neuroprotective and / or nerve regeneration effects. In addition, it also describes the pharmaceutical combination of FCB and fcb-aa with the first kind of interference, which has synergistic effect and can be reasonably used to treat central nervous system diseases with ischemic and neurodegenerative damage.La presente invención describe composiciones farmacéuticas que comprenden derivados de la C-Ficocianina como son la ficocianobilina (FCB) o péptidos cromogénicos de Ficocianobilina (FCB-aa), así como el uso en medicina de dichas composiciones para las cuales han sido demostrados efectos neuroprotectores y/o neuroregeneradores. Además describe combinaciones farmacéuticas de la FCB y FCB-aa con interferones del tipo I que, en efecto sinérgico, hacen racional su uso para el tratamiento de enfermedades del sistema nervioso central con daño isquémico y neurodegenerativo.
